SCHEMBL7916846

SCHEMBL7916846

FC(F)(F)c1nccn1-c1cnc(Cl)c(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.42
CHRNA4 P43681 2/20 0.42
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
NR1I2 O75469 1/20 0.35
HSD11B1 P28845 1/20 0.35
ALDH1A1 P00352 6/20 0.34
MAPT P10636 2/20 0.34
GAA P10253 1/20 0.34
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.32
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7919399 0.79 S100A9 (0.35) NR1I2HSD11B1ALDH1A1MAPT
SCHEMBL7909970 0.78 ADORA2A (0.35)
SCHEMBL7919587 0.73 CHRNB2 (0.46) CHRNB2CHRNA4NR1I2HSD11B1ALDH1A1
SCHEMBL28003186 0.71 NR1I2 (0.48) NR1I2HSD11B1ALDH1A1MAPTGAA
SCHEMBL28003240 0.71 MAPT (0.46) NR1I2HSD11B1MAPT
SCHEMBL8149329 0.70 PTGS2 (0.42) NR1I2HSD11B1ALDH1A1MAPTGAA
SCHEMBL8177172 0.70 NR1I2 (0.35) NR1I2HSD11B1
SCHEMBL26951482 0.69 CYP3A4 (0.36) NR1I2HSD11B1
SCHEMBL8118971 0.69 MAPT (0.36) NR1I2HSD11B1ALDH1A1MAPTLMNA
SCHEMBL3967152 0.67 L3MBTL1 (0.50) ALDH1A1GAAHTTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225320-B1 TREATMENT OF PAIN, INFLAMMATION, MIGRAINE, EMESIS AND POSTTHERPETIC NEURALGIA MERCK SHARP & DOHME LTD. (GB) 2001-05-01 US disclosed